19 September 2024
Duke Capital Limited
("Duke Capital", "Duke" or the "Company")
Interim Dividend and Dividend Declaration
Duke Capital Limited (AIM: DUKE), a leading provider of hybrid capital solutions for SME business owners in Europe and North America, is pleased to announce that the Board has approved an interim dividend of 0.70 pence (sterling) per share in respect of the second quarter of Duke's financial year.
The ex-dividend date is 26 September 2024, the record date is 27 September 2024 and the payment date is 14 October 2024.
***ENDS***
For further information, please visit www.dukecapital.com or contact:
| Duke Capital Limited | Neil Johnson / Charles Cannon Brookes / Hugo Evans
| +44 (0) 1481 231 816 |
| Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker) | Stephen Keys / Callum Davidson / Michael Johnson | +44 (0) 207 220 0500
|
| | | |
| Canaccord Genuity Limited (Joint Broker)
| Adam James / Harry Rees | +44 (0) 207 523 8000 |
| SEC Newgate (Financial Communications) | Elisabeth Cowell / Alice Cho / Matthew Elliott | + +44 (0) 20 3757 6882 dukecapital@secnewgate.co.uk |
About Duke Capital
Duke is a leading provider of hybrid capital solutions for SME business owners in Europe and North America, combining the best features of both equity and debt.
Since 2017, Duke has provided unique long-term financing which eliminates re-financing risk and necessity for a short-term exit by providing a unique 'corporate mortgage' while also aligning its returns to grow with the success of the business.
Duke is focused on generating attractive risk-adjusted returns for shareholders and has a track record of achieving this across market cycles. Its three investment pillars are capital preservation, attractive dividend yield, and to provide upside upon exits. Duke is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.